1 Subjects: “...Treatment Outcome...”

2

3 Subjects: “...Treatment Outcome...”

4 Subjects: “...Treatment Outcome...”

5 “... and biologic DMARDs). RESULTS: No head-to-head controlled trials meeting inclusion criteria existed for any...”

6 “... and biologic DMARDs). RESULTS: No head-to-head controlled trials meeting inclusion criteria existed for any...”

7 “... recommended treatment (isoniazid 300 mg daily for 24 weeks) for preventing active TB was published more than...”

8 “... recommended treatment (isoniazid 300 mg daily for 24 weeks) for preventing active TB was published more than...”

9 “...These limitations include (a) the predominance of single trials conducted by the treatment...”

10 “... disorders. Head-to-head trials have not consistently established the superiority of one medication. Thus...”

11 “... disorders. Head-to-head trials have not consistently established the superiority of one medication. Thus...”

12

13 “... with cycloplegic refraction or a comprehensive eye examination; RCTs of treatment compared with inactive controls...”

14 “... with cycloplegic refraction or a comprehensive eye examination; RCTs of treatment compared with inactive controls...”

15

16